166 related articles for article (PubMed ID: 34610940)
21. Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020.
Wagner R; Peterhoff D; Beileke S; Günther F; Berr M; Einhauser S; Schütz A; Niller HH; Steininger P; Knöll A; Tenbusch M; Maier C; Korn K; Stark KJ; Gessner A; Burkhardt R; Kabesch M; Schedl H; Küchenhoff H; Pfahlberg AB; Heid IM; Gefeller O; Überla K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200766
[TBL] [Abstract][Full Text] [Related]
22. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey.
Mutevedzi PC; Kawonga M; Kwatra G; Moultrie A; Baillie V; Mabena N; Mathibe MN; Rafuma MM; Maposa I; Abbott G; Hugo J; Ikalafeng B; Adelekan T; Lukhele M; Madhi SA
Int J Epidemiol; 2022 May; 51(2):404-417. PubMed ID: 34718591
[TBL] [Abstract][Full Text] [Related]
23. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.
Levin AT; Hanage WP; Owusu-Boaitey N; Cochran KB; Walsh SP; Meyerowitz-Katz G
Eur J Epidemiol; 2020 Dec; 35(12):1123-1138. PubMed ID: 33289900
[TBL] [Abstract][Full Text] [Related]
24. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
[TBL] [Abstract][Full Text] [Related]
25. A demographic scaling model for estimating the total number of COVID-19 infections.
Bohk-Ewald C; Dudel C; Myrskylä M
Int J Epidemiol; 2021 Jan; 49(6):1963-1971. PubMed ID: 33349859
[TBL] [Abstract][Full Text] [Related]
26. Mortality Rates of Coronavirus Disease 2019 (COVID-19) Caused by the Novel Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).
Kandi V; Thungaturthi S; Vadakedath S; Gundu R; Mohapatra RK
Cureus; 2021 Mar; 13(3):e14081. PubMed ID: 33903841
[TBL] [Abstract][Full Text] [Related]
27. Date of introduction and epidemiologic patterns of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Mogadishu, Somalia: estimates from transmission modelling of satellite-based excess mortality data in 2020.
Koltai M; Warsame A; Bashiir F; Freemantle T; Reeve C; Williams C; Jit M; Flasche S; Davies NG; ; Aweis A; Ahmed M; Dalmar A; Checchi F
Wellcome Open Res; 2021; 6():255. PubMed ID: 35299709
[No Abstract] [Full Text] [Related]
28. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
COVID-19 Excess Mortality Collaborators
Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
[TBL] [Abstract][Full Text] [Related]
29. High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya.
Ngere I; Dawa J; Hunsperger E; Otieno N; Masika M; Amoth P; Makayotto L; Nasimiyu C; Gunn BM; Nyawanda B; Oluga O; Ngunu C; Mirieri H; Gachohi J; Marwanga D; Munywoki PK; Odhiambo D; Alando MD; Breiman RF; Anzala O; Njenga MK; Bulterys M; Herman-Roloff A; Osoro E
Int J Infect Dis; 2021 Nov; 112():25-34. PubMed ID: 34481966
[TBL] [Abstract][Full Text] [Related]
30. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD;
PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774
[TBL] [Abstract][Full Text] [Related]
31. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
[TBL] [Abstract][Full Text] [Related]
32. First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate.
Vial PA; González C; Apablaza M; Vial C; Lavín ME; Araos R; Rubilar P; Icaza G; Florea A; Pérez C; Concha P; Bastías D; Errázuriz MP; Pérez R; Guzmán F; Olea A; Guzmán E; Correa J; Munita JM; Aguilera X
Epidemics; 2022 Sep; 40():100606. PubMed ID: 35872438
[TBL] [Abstract][Full Text] [Related]
33. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
Anand S; Montez-Rath M; Han J; Cadden L; Hunsader P; Kerschmann R; Beyer P; Boyd SD; Garcia P; Dittrich M; Block GA; Parsonnet J; Chertow GM
JAMA Netw Open; 2021 Jul; 4(7):e2116572. PubMed ID: 34251441
[TBL] [Abstract][Full Text] [Related]
34. A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.
Meyerowitz-Katz G; Merone L
Int J Infect Dis; 2020 Dec; 101():138-148. PubMed ID: 33007452
[TBL] [Abstract][Full Text] [Related]
35. Are COVID-19 age-mortality curves for 2020 flatter in developing countries? Evidence from a cross-sectional observational study of population-level official death counts and excess deaths estimates.
Demombynes G; de Walque D; Gubbins P; Urdinola P; Veillard J
BMJ Open; 2022 Nov; 12(11):e061589. PubMed ID: 36351719
[TBL] [Abstract][Full Text] [Related]
36. [Infection fatality rate (IFR) during the course of COVID-19 pandemic in Upper Silesia Metropolitan Area (Poland) in 2020].
Zejda JE; Kowalska M; Brożek GM; Barański K; Kaleta-Pilarska A
Med Pr; 2021 Dec; 72(6):671-676. PubMed ID: 34751682
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
38. Subnational mortality estimates for India in 2019: a baseline for evaluating excess deaths due to the COVID-19 pandemic.
Rao C; John AJ; Yadav AK; Siraj M
BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34824138
[TBL] [Abstract][Full Text] [Related]
39. The burden of COVID-19 infection in a rural Tamil Nadu community.
Isaac R; Paul B; Finkel M; Moorthy M; Venkateswaran S; Bachmann TT; Pinnock H; Norrie J; Ramalingam S; Minz S; Hansdak S; Blythe R; Keller M; Muliyil J; Weller D
BMC Infect Dis; 2021 Oct; 21(1):1110. PubMed ID: 34711193
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of COVID-19 infection among vaccine naïve population after the second surge (June 2020) in a rural district of South India: A community-based cross-sectional study.
George CE; Inbaraj LR; Rajukutty S; Joan RF; Suseeladevi AK; Muthuraj S; Chandrasingh S
PLoS One; 2022; 17(3):e0265236. PubMed ID: 35271669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
